Lineage Cell Therapeutics
LCTX
#8742
Rank
โ‚น10.09 B
Marketcap
โ‚น45.79
Share price
-1.91%
Change (1 day)
-50.84%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Net assets

Net assets on the balance sheet as of September 2024 : โ‚น5.51 Billion

According to Lineage Cell Therapeutics 's latest financial reports the company has โ‚น5.51 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lineage Cell Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚น5.16 B-13.26%
2022-12-31$โ‚น5.95 B-12.02%
2021-12-31$โ‚น6.76 B-2.75%
2020-12-31$โ‚น6.95 B-12.3%
2019-12-31$โ‚น7.93 B22.99%
2018-12-31$โ‚น6.45 B-38.5%
2017-12-31$โ‚น10.48 B18.26%
2016-12-31$โ‚น8.86 B74.57%
2015-12-31$โ‚น5.08 B27.8%
2014-12-31$โ‚น3.97 B52.25%
2013-12-31$โ‚น2.61 B96.29%
2012-12-31$โ‚น1.33 B-39.35%
2011-12-31$โ‚น2.19 B-0.98%
2010-12-31$โ‚น2.21 B332.08%
2009-12-31$โ‚น0.51 B-345.34%
2008-12-31$-โ‚น0.21 Billion74.76%
2007-12-31$-โ‚น0.12 Billion44.72%
2006-12-31$-โ‚น82.62 Million833.86%
2005-12-31$-โ‚น8.85 Million-159.25%
2004-12-31$โ‚น14.93 M-113.49%
2003-12-31$-โ‚น0.12 Billion97.04%
2002-12-31$-โ‚น56.17 Million1074.58%
2001-12-31$-โ‚น4.79 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚น23.32 B 322.87%๐Ÿ‡บ๐Ÿ‡ธ USA